Navigation Links
Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Date:4/28/2009

Test for Mycobacterium tuberculosis (TB) Expected to Highlight Broad On-Demand CE IVD Test Menu at Booth #611

SUNNYVALE, Calif., April 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced speaker and program highlights for its symposium, "Patient Management in the Era of Rapid Diagnostics," which the company will host at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), taking place in Finland next month. The company also announced the menu of CE IVD molecular diagnostic tests to be featured in booth #611 on the exhibition floor.

Dr. Fred Tenover, Ph.D., Cepheid's Senior Director of Scientific Affairs, will chair the symposium where leading microbiology and infection control specialists will present data on the clinical impact of rapid, on-demand molecular diagnostic testing.

The Cepheid Symposium, "Patient Management in the Era of Rapid Diagnostics," will take place at 9:00 a.m. on Sunday, 17 May in Hall 3F. The agenda is as follows:

    9:00   MRSA in Paediatric Patients: What Rapid Testing Reveals
           Presented by Dr. Jim Gray, Senior Microbiologist, Birmingham
           Children's Hospital
    9:30   Detecting C. difficile: Slowly or Quickly?
           Presented by Professor Mark Wilcox, Professor in Medical
           Microbiology, Institute of Molecular and Cellular Biology, Leeds
    10:00  Do We Need Rapid Tests to Detect Tuberculosis and Rifampicin
           Resistance?
           Presented by Dr. Sabine Ruesch-Gerdes, National Reference Centre
           for Mycobacteria, Borstel, Germany
    10:30  Will Community MRSA and C. difficile Change Infection Control in
           Hospitals?
           Presented by Dr. Fred Tenover, Cepheid, Sunnyvale, CA

"The 19th ECCMID Congress is shaping
'/>"/>

SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cepheid Reports 2009 First Quarter Results
2. Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
3. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Cepheid to Webcast Upcoming Financial Presentations
6. Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
7. Cepheid Reports Third Quarter Revenue of $44.9 Million
8. Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
9. Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized Moderate Complexity by FDA
10. Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
11. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... The empty capsules market is experiencing ... and technological innovations in the empty capsules market. ... the growth of the empty capsules market. , ... Scope of Report , The report will enrich ... firms to gauge the pulse of the market ...
(Date:12/19/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... announced the results of its annual general meeting of ... year in Relmada,s history and it set the stage ... Sergio Traversa , chief executive officer of Relmada. "Over ... human resource and clinical development objectives that position Relmada ...
(Date:12/17/2014)... BASKING RIDGE, N.J. (PRWEB) December 17, 2014 ... Ipsen (Euronext: IPN; ADR: IPSEY), ... 120 mg (referred to as Somatuline®) was approved ... for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ... differentiated, locally advanced or metastatic disease to improve ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Audacity, ... activation agency and member of the Huntsworth Health Group, ... to its executive team. In her role, Gonzales will ... , “We are incredibly honored to welcome a talent ... Chief and CEO, Gaëtan Fraikin. “She is a proven ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... businesses will receive funding for their technology development projects through ... , , BioSystem Development LLC of Middleton, will receive ... protein analysis. The company will use this award to finish ... university spin-off, we have not had the benefit of ...
... David Redick knows something about venture capital, having received ... entrepreneur. , ,Now Redick, a longtime denizen of Silicon ... the other side of the aisle with Badger ... focused on providing early stage funding and management services ...
... voted late Tuesday night to amend a bill granting ... newly created human embryonic stem cells would be denied. ... firms that do any research involving the destruction of ... cells from them after August 9, 2001. It ...
Cached Biology Technology:New Madison VC firm Badger Ventures looks for next big IT entrepreneurs 2New Madison VC firm Badger Ventures looks for next big IT entrepreneurs 3Bill would deny tax credits to firms creating stem-cell cultures 2
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "iPhone 5S Fingerprint ... Report" report to their offering. ... the acquisition of AuthenTec in July 2012, Apple ... 5S. It is currently the only device of ...
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., ... of a study that pinpoints fine-scale differences in genetic ... States . Since immigrants first arrived ... United States has served as a meeting ... how American history and the ongoing mixing of peoples ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 323andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... of Earth observation missions expanding, it makes sense ... mission control from a combined Dedicated Control Room. ... and generating improved economic returns. , Flight control ... out of a combined Earth Observation (EO) Dedicated ...
... today announced details of a membership agreement with BioMed ... by its researchers. Pfizer,s BioMed Central membership arrangement ... for any researcher employed or funded by Pfizer when ... Central,s 190+ peer-reviewed open access journals. By funding open ...
... down on a Honduran naval boat as it criss-crossed the ... Central Americas most important seaports. Aboard the vessel, Miguel ... the distant horizon with some hint of concern on his ... the last few readings were definitely off. Miguel, along ...
Cached Biology News:ESA's Earth observation missions: Sharing teams and facilities boosts efficiency 2ESA's Earth observation missions: Sharing teams and facilities boosts efficiency 3Searching for pollution in the Caribbean 2Searching for pollution in the Caribbean 3Searching for pollution in the Caribbean 4Searching for pollution in the Caribbean 5Searching for pollution in the Caribbean 6Searching for pollution in the Caribbean 7Searching for pollution in the Caribbean 8
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
... Disciple thermal cycler is a dual-bay expansion ... be operated independently, using a PC. The ... Alpha units (sample-holder, heat-pump assemblies), which hold ... Chromo4 real-time detector. Peltier heat pumps provide ...
...
I-Ab MHC Class II...
Biology Products: